Recombinant protein and application thereof in prevention of HPV (human papillomavirus)
The invention discloses a recombinant protein and application thereof in prevention of HPV (human papillomavirus), and belongs to the field of biological medicine. The recombinant protein comprises one or more of five serotype L2 protein fragments of HPV (human papillomavirus), wherein the five serotype L2 protein fragments of HPV are selected from 6 (13-75), 16 (11-75), 18 (12-75), 31 (11-75) and 39 (12-75). The recombinant protein and a composition of the recombinant protein and different adjuvants can simultaneously generate good prevention and/or treatment effects on 17 subtypes of HPV (Human Papilloma Virus) 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 and 73, so that efficient prevention and/or treatment of HPV is realized..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 23. Jan. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
HAN ZHENWEI [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-01-23, Last update posted on www.tib.eu: 2024-03-25, Last updated: 2024-03-29 |
|---|
| Patentnummer: |
CN117430674 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA00271969X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA00271969X | ||
| 003 | DE-627 | ||
| 005 | 20240329160217.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240329s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA00271969X | ||
| 035 | |a (EPA)CN117430674 | ||
| 035 | |a (EPA)89548579 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a HAN ZHENWEI |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recombinant protein and application thereof in prevention of HPV (human papillomavirus) |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-01-23, Last update posted on www.tib.eu: 2024-03-25, Last updated: 2024-03-29 | ||
| 520 | |a The invention discloses a recombinant protein and application thereof in prevention of HPV (human papillomavirus), and belongs to the field of biological medicine. The recombinant protein comprises one or more of five serotype L2 protein fragments of HPV (human papillomavirus), wherein the five serotype L2 protein fragments of HPV are selected from 6 (13-75), 16 (11-75), 18 (12-75), 31 (11-75) and 39 (12-75). The recombinant protein and a composition of the recombinant protein and different adjuvants can simultaneously generate good prevention and/or treatment effects on 17 subtypes of HPV (Human Papilloma Virus) 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 and 73, so that efficient prevention and/or treatment of HPV is realized. | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C12R: Indexing scheme associated with subclasses c12c-c12q, relating to microorganisms | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a MU TING |4 aut | |
| 700 | 0 | |a ZHAO PING |4 aut | |
| 700 | 0 | |a WANG SHEN |4 aut | |
| 700 | 0 | |a XU LONG |4 aut | |
| 700 | 0 | |a ZHANG YING |4 aut | |
| 700 | 0 | |a XIE LIANG |4 aut | |
| 700 | 0 | |a WU YUE |4 aut | |
| 700 | 0 | |a ZHAO JIN |4 aut | |
| 700 | 0 | |a KE MEIQIANG |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 23. Jan. |
| 773 | 1 | 8 | |g year:2024 |g day:23 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/89548579/publication/CN117430674A1?q=CN117430674 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 23 |c 01 | ||